Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Global Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028
... on the autoimmune hemolytic anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Iron Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Bone Marrow Transplant Market, By Type (Autologous Transplant, Allogenic Transplant, Others), By Treatment Type (Leukemia , Lymphoma, Myeloma, Myelodysplastic Syndrome, Myeloproliferative Disorders, Aplastic Anemia, Solid Tumors, Sickle cell Anemia, Thalassemia, Others), By End User (Hospitals, Multi-specialty Clinics, Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Multi-specialty Clinics, Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Bone marrow transplant is a procedure that infuses healthy bone marrow stem cells to replace the damaged ... Read More
-
Global Sickle Cell Anemia Therapeutics Competitive Landscape Professional Research Report 2024
... a genetic disorder characterized by abnormal hemoglobin production. Therapeutic approaches for sickle cell anemia may include disease-modifying medications such as hydroxyurea, which increases fetal hemoglobin production and reduces the frequency of painful vaso-occlusive crises. Other ... Read More
-
Global Hemophilia Gene Therapy Competitive Landscape Professional Research Report 2024
... Typically, hemophilia gene therapy involves introducing a functional copy of the clotting factor gene into the patient＇s cells, often using viral vectors as delivery vehicles. The goal is to enable the patient＇s cells to produce ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.04 billion in 2024, at a CAGR 6.10% to reach USD 8.63 billion by 2030. The hemoglobin testing market comprises various diagnostic products, services, and technologies that healthcare ... Read More
-
Sickle Cell Anemia Testing & Screening Market by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests), Age Group (Adult Screening, Newborn Screening, Years 1 to 25), Sector - Global Forecast 2024-2030
... Anemia Testing & Screening Market size was estimated at USD 943.95 million in 2023 and expected to reach USD 1,070.69 million in 2024, at a CAGR 13.51% to reach USD 2,293.22 million by 2030. Sickle ... Read More
-
Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... CAGR of 7.20% during the period spanning 2024-2028. The growth in the market has been driven by factors like rising geriatric population, increasing prevalence of genetic disorders, government initiatives, rising demand for albumin, escalating use ... Read More
-
Renal Anemia – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Renal Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Renal Anemia market report provides current treatment practices, emerging drugs, Renal ... Read More
-
Thalassemia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Thalassemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Thalassemia market report provides current treatment practices, emerging drugs, Thalassemia market share of the individual ... Read More
-
Acquired hemophilia A – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Acquired hemophilia A market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acquired hemophilia A market report provides current ... Read More
-
Anemia In Chronic Kidney Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... the Anemia In Chronic Kidney Disease, historical and forecasted epidemiology as well as the Anemia In Chronic Kidney Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Hemophilia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Hemophilia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hemophilia market report provides current treatment practices, emerging drugs, Hemophilia market share of the individual ... Read More
-
Coagulation Factor Deficiency – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Coagulation Factor Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Coagulation Factor Deficiency market report provides current ... Read More
-
Anemia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Anemia market report provides current treatment practices, emerging drugs, Anemia market share of the individual ... Read More
-
Hemophilia with Inhibitor – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Hemophilia with Inhibitor market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hemophilia with Inhibitor market report provides current ... Read More
-
Anemia in Elderly – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Anemia in Elderly market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Anemia in Elderly market report provides current ... Read More
-
Sickle Cell Disease - Epidemiology Forecast - 2034
... The prevalence of SCD cases was found to be high and rapidly increasing in the 6MM countries. However, in Japan, SCD is rare due to Japan's homogeneous population, which makes it less likely for the ... Read More
-
Sickle Cell Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) The global sickle cell disease treatment market encounters numerous challenges that impede its revenue growth. These challenges stem from inadequate healthcare infrastructure, unavailability of drugs in rural regions, lack of reimbursement, high treatment costs, ... Read More
-
India Thalassemia Market Research Report - Forecast to 2032
... an abnormal kind of haemoglobin. It causes a huge number of blood cells to be destroyed, resulting in anaemia. Thalassemia is a genetic condition caused by the deletion or modification of a specific gene segment. ... Read More
-
India Sickle Cell Anaemia Market Research Report Forecast to 2032
... disorder characterized by the presence of abnormal hemoglobin that causes red blood cells to become rigid and sickle shaped. It happens due to a mutation on the sixth position of the beta chain of hemoglobin ... Read More
-
Hemophilia B - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
2024 Global Forecast for Plasma Fractionation Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Rare Hemophilia Factors Databank Market Report
... 2021 to 2029. Factor II segment is expected to be the highest contributor to this market, with $1,123.8 Million in 2020, and is anticipated to reach $1,801.8 Million by 2029, registering a CAGR of 5.44%. ... Read More
Research Assistance
